Elicio Therapeutics, Inc. Gain (Loss) on Extinguishment of Debt
Elicio Therapeutics, Inc. (ELTX) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2025-03-31
- Elicio Therapeutics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Elicio Therapeutics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was $0.00.
- Elicio Therapeutics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Elicio Therapeutics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-03-31 was $0.00.
- Elicio Therapeutics, Inc. gain (loss) on extinguishment of debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Elicio Therapeutics, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was $605.00K, a 30150.00% increase from fiscal 2022.
- Elicio Therapeutics, Inc. gain (loss) on extinguishment of debt for fiscal 2022 was $2.00K, a 99.78% decline from fiscal 2021.
- Elicio Therapeutics, Inc. gain (loss) on extinguishment of debt for fiscal 2021 was $905.00K.
| Period end | Gain (Loss) on Extinguishment of Debt | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $0.00 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $1.00K derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $1.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.00K derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2024-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2025-03-31 | $1.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.00K derived: sum of 3 quarters · filed 2025-03-31 | $605.00K derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.00K derived: sum of 2 quarters · filed 2025-03-31 | $605.00K derived: sum of 3 quarters · filed 2025-03-31 | $605.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 | $604.00K derived: sum of 2 quarters · filed 2024-11-13 | $604.00K 10-Q · filed 2024-11-13 | $583.00K derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $604.00K 10-Q · filed 2024-08-13 | $604.00K 10-Q · filed 2024-08-13 | $583.00K derived: sum of 3 quarters · filed 2024-08-13 | $583.00K derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-06-01 | $600.00K 10-K · filed 2025-03-31 | |||||
| 2023-03-31 | -$23.00K 10-Q · filed 2023-05-10 | -$21.00K derived: sum of 2 quarters · filed 2024-03-29 | -$21.00K derived: sum of 3 quarters · filed 2024-03-29 | -$21.00K derived: sum of 4 quarters · filed 2024-03-29 | ||
| 2022-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $2.00K derived: sum of 2 quarters · filed 2024-03-29 | $2.00K derived: sum of 3 quarters · filed 2024-03-29 | $2.00K 10-K · filed 2024-03-29 | $0.00 10-K · filed 2023-03-17 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2023-08-14 | $0.00 derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-05-10 | $0.00 derived: sum of 3 quarters · filed 2023-05-10 | $905.00K derived: sum of 4 quarters · filed 2023-05-10 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $0.00 derived: sum of 2 quarters · filed 2023-03-17 | $905.00K derived: sum of 3 quarters · filed 2023-03-17 | $905.00K 10-K · filed 2023-03-17 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $905.00K derived: sum of 2 quarters · filed 2022-11-14 | $905.00K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $905.00K 10-Q · filed 2022-08-15 | $905.00K 10-Q · filed 2022-08-15 | ||||
| 2021-05-26 | $900.00K 10-K · filed 2023-03-17 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $0.00 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |